Bank of Montreal
ADVM

Bank of Montreal’s Adverum Biotechnologies ADVM Stock Holding History

Bank of Montreal’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,242
Closed -$130K – 3825
2024
Q2 		$130K Buy
+16,242
New +$151K ﹤0.01% 3166
2021
Q2 		– Sell
-288
Closed -$28K – 3643
2021
Q1 		$28K Sell
288
-1,092
-79% -$131K ﹤0.01% 3921
2020
Q4 		$168K Buy
1,380
+964
+232% +$119K ﹤0.01% 3321
2020
Q3 		$43K Sell
416
-181
-30% -$27.1K ﹤0.01% 3498
2020
Q2 		$126K Buy
+597
New +$106K ﹤0.01% 2977
2020
Q1 		– Sell
-682
Closed -$79K – 4051
2019
Q4 		$79K Buy
682
+208
+44% +$18.3K ﹤0.01% 3606
2019
Q3 		$26K Buy
474
+24
+5% +$2.71K ﹤0.01% 3934
2019
Q2 		$54K Buy
+450
New +$37.2K ﹤0.01% 3651
2019
Q1 		– Sell
-77
Closed -$2K – 4270
2018
Q4 		$2K Buy
77
+39
+103% +$1.59K ﹤0.01% 4335
2018
Q3 		$2K Sell
38
-1
-3% -$56 ﹤0.01% 4310
2018
Q2 		$2K Buy
+39
New +$2.35K ﹤0.01% 4314
2017
Q1 		– Sell
-109
Closed -$3K – 3944
2016
Q4 		$3K Buy
109
+28
+35% +$915 ﹤0.01% 3811
2016
Q3 		$3K Hold
81
– – ﹤0.01% 3786
2016
Q2 		$3K Buy
81
+52
+179% +$2.35K ﹤0.01% 3831
2016
Q1 		$2K Buy
+29
New +$1.62K ﹤0.01% 3959
2015
Q3 		– Sell
-2,130
Closed -$346K – 3964
2015
Q2 		$346K Buy
2,130
+1,267
+147% +$427K ﹤0.01% 2159
2015
Q1 		$350K Sell
863
-183
-17% -$77.4K ﹤0.01% 2111
2014
Q4 		$565K Buy
1,046
+270
+35% +$104K ﹤0.01% 2004
2014
Q3 		$265K Buy
+776
New +$231K ﹤0.01% 2396

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Bank of Montreal's ADVM Position: Q3 2024 in Review

Bank of Montreal sold out of Adverum Biotechnologies (ADVM) in Q3 2024, closing a stake of 16,242 shares — an estimated $130K sold.

Bank of Montreal first reported a position in ADVM in Q3 2014 and held it in 19 quarters. The position peaked at $565K in Q4 2014. 77 funds tracked by Wall St. Rank hold ADVM as of Q3 2024.

  • Bank of Montreal reported no remaining Adverum Biotechnologies position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 16,242 Adverum Biotechnologies shares in Q3 2024, an estimated $130K.
  • Bank of Montreal first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 19 quarters.
  • Bank of Montreal's Adverum Biotechnologies position peaked at $565K in Q4 2014.
  • 77 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.